Search research articles
Contact Us
Filters
Showing results (191-200 of 359) with videos related to
Page
of 36
Sort By:
The American Journal of Pathology
|
January 1, 2014
βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion
Maria C Tsourlakis, Philipp Weigand, Katharina Grupp, et al.
Scientific Reports
|
August 10, 2022
Follow-up of men with a PI-RADS 4/5 lesion after negative MRI/Ultrasound fusion biopsy
Kira Kornienko, Miriam Reuter, Andreas Maxeiner, et al.
Clinical Epigenetics
|
October 24, 2019
Random forest-based modelling to detect biomarkers for prostate cancer progression
Reka Toth, Heiko Schiffmann, Claudia Hube-Magg, et al.
Journal of Clinical Medicine
|
December 10, 2021
Outcomes of Deceased Donor Kidney Transplantation in the Eurotransplant Senior Program with A Focus on Recipients ≥75 Years
Ilias Zompolas, Robert Peters, Lutz Liefeldt, et al.
The Journal of Urology
|
February 13, 2014
A tertiary Gleason pattern in the prostatectomy specimen and its association with adverse outcome after radical prostatectomy
Meike Adam, Amir Hannah, Lars Budäus, et al.
Human Pathology
|
February 22, 2015
Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers
Christoph Burdelski, Ysé Barreau, Ronald Simon, et al.
Urology
|
August 12, 2008
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer
Umberto Capitanio, Sasha Ahyai, Markus Graefen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 17, 2008
Clinical significance of p53 alterations in surgically treated prostate cancers
Thorsten Schlomm, Liv Iwers, Patrick Kirstein, et al.
Clinical Chemistry
|
October 12, 2019
Tumor-Associated Release of Prostatic Cells into the Blood after Transrectal Ultrasound-Guided Biopsy in Patients with Histologically Confirmed Prostate Cancer
Simon A Joosse, Burkhard Beyer, Christin Gasch, et al.
British Journal of Cancer
|
September 9, 2020
EGFR as a stable marker of prostate cancer dissemination to bones
Paulina Nastały, Sara Stoupiec, Marta Popęda, et al.
Page
of 36
Search research articles
Search
Showing results (191-200 of 359) with videos related to
Sort By:
Page
of 36
The American Journal of Pathology
|
January 1, 2014
βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion
Maria C Tsourlakis, Philipp Weigand, Katharina Grupp, et al.
Scientific Reports
|
August 10, 2022
Follow-up of men with a PI-RADS 4/5 lesion after negative MRI/Ultrasound fusion biopsy
Kira Kornienko, Miriam Reuter, Andreas Maxeiner, et al.
Clinical Epigenetics
|
October 24, 2019
Random forest-based modelling to detect biomarkers for prostate cancer progression
Reka Toth, Heiko Schiffmann, Claudia Hube-Magg, et al.
Journal of Clinical Medicine
|
December 10, 2021
Outcomes of Deceased Donor Kidney Transplantation in the Eurotransplant Senior Program with A Focus on Recipients ≥75 Years
Ilias Zompolas, Robert Peters, Lutz Liefeldt, et al.
The Journal of Urology
|
February 13, 2014
A tertiary Gleason pattern in the prostatectomy specimen and its association with adverse outcome after radical prostatectomy
Meike Adam, Amir Hannah, Lars Budäus, et al.
Human Pathology
|
February 22, 2015
Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers
Christoph Burdelski, Ysé Barreau, Ronald Simon, et al.
Urology
|
August 12, 2008
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer
Umberto Capitanio, Sasha Ahyai, Markus Graefen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 17, 2008
Clinical significance of p53 alterations in surgically treated prostate cancers
Thorsten Schlomm, Liv Iwers, Patrick Kirstein, et al.
Clinical Chemistry
|
October 12, 2019
Tumor-Associated Release of Prostatic Cells into the Blood after Transrectal Ultrasound-Guided Biopsy in Patients with Histologically Confirmed Prostate Cancer
Simon A Joosse, Burkhard Beyer, Christin Gasch, et al.
British Journal of Cancer
|
September 9, 2020
EGFR as a stable marker of prostate cancer dissemination to bones
Paulina Nastały, Sara Stoupiec, Marta Popęda, et al.
Page
of 36